Clinical Trial Update: Management of Women With BRCA1/2 Mutation

View source ↗

Summary

This clinical trial update covers management strategies for women with BRCA1/2 mutations. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hereditary Breast and Ovarian Cancer Syndrome
• Ovarian Cancer

Snippet

Sponsor: University Hospital, Montpellier | Conditions: BRCA1 Mutation, BRCA2 Mutation | Status: COMPLETED